May 30, 2020 / 8:54 PM / a month ago

Mallinckrodt can't avoid consequences of Medicaid rebate ruling: judge

May 30 -

A federal judge on Friday rejected Mallinckrodt Plc’s request to reconsider or put on hold a ruling that allowed the U.S. government to force the drugmaker to pay higher rebates to state Medicaid programs after it dramatically hiked the price of its top-selling drug.

U.S. District Judge Thomas Hogan in Washington, D.C., declined to reconsider an earlier ruling from March that will force Mallinckrodt to pay $650 million to cover retroactive rebates for the drug, H.P. Acthar Gel.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below